NKG2D blockade prevents autoimmune diabetes in NOD mice
- PMID: 15189740
- DOI: 10.1016/j.immuni.2004.05.008
NKG2D blockade prevents autoimmune diabetes in NOD mice
Abstract
NKG2D is an activating receptor on CD8(+) T cells and NK cells that has been implicated in immunity against tumors and microbial pathogens. Here we show that RAE-1 is present in prediabetic pancreas islets of NOD mice and that autoreactive CD8(+) T cells infiltrating the pancreas express NKG2D. Treatment with a nondepleting anti-NKG2D monoclonal antibody (mAb) during the prediabetic stage completely prevented disease by impairing the expansion and function of autoreactive CD8(+) T cells. These findings demonstrate that NKG2D is essential for disease progression and suggest a new therapeutic target for autoimmune type I diabetes.
Comment in
-
Intraepithelial lymphocytes in celiac disease: license to kill revealed.Immunity. 2004 Sep;21(3):303-4. doi: 10.1016/j.immuni.2004.08.002. Immunity. 2004. PMID: 15357941
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
